IRON ACQUISITION BY STAPHYLOCOCCI

葡萄球菌获取铁

基本信息

  • 批准号:
    3078886
  • 负责人:
  • 金额:
    $ 5.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-09-01 至 1994-08-31
  • 项目状态:
    已结题

项目摘要

The growth of staphylococci can be inhibited by aportransferrin, the serum iron-binding protein. Presumably, growth during human infections is also dependent on the ability of staphylococci to acquire iron from the host. Although previous research has examined the mechanisms by which gram-negative organisms acquire iron, little work has been done to elucidate the mechanisms used by gram-positive organisms. For decades, Staphylococcus aureus has been an important cause of community- and hospital-acquired bloodstream infections. Recently Staphylococcus epidermidis has become one of the most common causes of nosocomial bloodstream infections. Yet little is known about the mechanisms by which staphylococci compete with apotransferrin. The long-term objective of the proposal is to develop a comprehensive picture of the mechanisms by which staphylococci acquire iron. Assays of (55)Fe uptake from various substrates, including apotransferrin, will be used to determine which serve as iron sources. Mechanisms used by other bacteria will be evaluated to determine whether they have a role in iron acquisition by staphylococci: bacterial iron chelators (siderophores), bacterial reductases, bacteria- or host-derived organic acids. Mechanisms used by S. aureus will be compared and contrasted with those used by the less virulent staphylococcal species. The Clinical Investigator Award will enable the Principal Investigator (PI) to address critical questions regarding the pathogenesis of staphylococcal infections. The data will give important insights into the differences between infections caused by S. aureus and by less virulent staphylococcal species. The goal is to develop the antibacterial activity of iron deprivation into new approaches for the prevention and treatment of staphylococcal infections. In addition, the PI will gain experience essential for her future career as an independent investigator.
葡萄球菌的生长可被血清转铁蛋白抑制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Loreen A Herwaldt其他文献

Loreen A Herwaldt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Loreen A Herwaldt', 18)}}的其他基金

Infection Prevention and Antimicrobial Stewardship: Minding the Gaps: The Iowa Prevention Epicenter
感染预防和抗菌药物管理:弥补差距:爱荷华州预防中心
  • 批准号:
    10466716
  • 财政年份:
    2021
  • 资助金额:
    $ 5.36万
  • 项目类别:
Infection Prevention and Antimicrobial Stewardship: Minding the Gaps: The Iowa Prevention Epicenter
感染预防和抗菌药物管理:弥补差距:爱荷华州预防中心
  • 批准号:
    10653046
  • 财政年份:
    2021
  • 资助金额:
    $ 5.36万
  • 项目类别:
Infection Prevention and Antimicrobial Stewardship: Minding the Gaps: The Iowa Prevention Epicenter
感染预防和抗菌药物管理:弥补差距:爱荷华州预防中心
  • 批准号:
    10406852
  • 财政年份:
    2021
  • 资助金额:
    $ 5.36万
  • 项目类别:
Implementation and Effectiveness of a S. aureus Surgical Site Infection Preventio
金黄色葡萄球菌手术部位感染预防的实施和有效性
  • 批准号:
    8608222
  • 财政年份:
    2013
  • 资助金额:
    $ 5.36万
  • 项目类别:
Statewide Implementation of Guidelines to Control MRSA
全州范围内实施 MRSA 控制指南
  • 批准号:
    7686323
  • 财政年份:
    2007
  • 资助金额:
    $ 5.36万
  • 项目类别:
Statewide Implementation of Guidelines to Control MRSA
全州范围内实施 MRSA 控制指南
  • 批准号:
    7405902
  • 财政年份:
    2007
  • 资助金额:
    $ 5.36万
  • 项目类别:
Statewide Implementation of Guidelines to Control MRSA
全州范围内实施 MRSA 控制指南
  • 批准号:
    7498045
  • 财政年份:
    2007
  • 资助金额:
    $ 5.36万
  • 项目类别:
Blood Product Tranfusions & Safe Practices Implementaion
血液制品输注
  • 批准号:
    6805144
  • 财政年份:
    2003
  • 资助金额:
    $ 5.36万
  • 项目类别:
Blood Product Tranfusions & Safe Practices Implementaion
血液制品输注
  • 批准号:
    6782196
  • 财政年份:
    2003
  • 资助金额:
    $ 5.36万
  • 项目类别:
IRON ACQUISITION BY STAPHYLOCOCCI
葡萄球菌获取铁
  • 批准号:
    3078885
  • 财政年份:
    1991
  • 资助金额:
    $ 5.36万
  • 项目类别:

相似海外基金

Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
  • 批准号:
    10679628
  • 财政年份:
    2023
  • 资助金额:
    $ 5.36万
  • 项目类别:
Molecular Mechanisms of Staphylococcus Epidermidis Strain Diversity
表皮葡萄球菌菌株多样性的分子机制
  • 批准号:
    10539139
  • 财政年份:
    2021
  • 资助金额:
    $ 5.36万
  • 项目类别:
Molecular Mechanisms of Staphylococcus Epidermidis Strain Diversity
表皮葡萄球菌菌株多样性的分子机制
  • 批准号:
    10328966
  • 财政年份:
    2021
  • 资助金额:
    $ 5.36万
  • 项目类别:
Molecular Mechanisms of Staphylococcus Epidermidis Strain Diversity
表皮葡萄球菌菌株多样性的分子机制
  • 批准号:
    10412521
  • 财政年份:
    2021
  • 资助金额:
    $ 5.36万
  • 项目类别:
Structural variation of wall teichoic acid polymers and its role for colonization capacity, virulence, and evolution of Staphylococcus epidermidis
壁磷壁酸聚合物的结构变化及其对表皮葡萄球菌定植能力、毒力和进化的作用
  • 批准号:
    410190180
  • 财政年份:
    2019
  • 资助金额:
    $ 5.36万
  • 项目类别:
    Research Grants
Molecular Mechanisms Underlying Transition to Virulence in Staphylococcus epidermidis
表皮葡萄球菌毒力转变的分子机制
  • 批准号:
    10392839
  • 财政年份:
    2018
  • 资助金额:
    $ 5.36万
  • 项目类别:
Molecular Mechanisms Underlying Transition to Virulence in Staphylococcus epidermidis
表皮葡萄球菌毒力转变的分子机制
  • 批准号:
    9906753
  • 财政年份:
    2018
  • 资助金额:
    $ 5.36万
  • 项目类别:
Topical application of heterologous protein-expressing Staphylococcus epidermidis for potential therapeutic treatment of skin diseases
表达异源蛋白的表皮葡萄球菌的局部应用对皮肤病的潜在治疗作用
  • 批准号:
    9202769
  • 财政年份:
    2016
  • 资助金额:
    $ 5.36万
  • 项目类别:
Molecular basis of giant Extracellular Matrix Binding Protein (Embp) mediated Staphylococcus epidermidis adherence to fibronectin and biofilm accumulation on artificial surfaces
巨型细胞外基质结合蛋白(Embp)介导表皮葡萄球菌粘附于纤连蛋白和人工表面生物膜积累的分子基础
  • 批准号:
    246586217
  • 财政年份:
    2013
  • 资助金额:
    $ 5.36万
  • 项目类别:
    Research Grants
Heterogeneous gene expression, metabolic variability and differentiation in Staphylococcus epidermidis biofilms
表皮葡萄球菌生物膜的异质基因表达、代谢变异和分化
  • 批准号:
    217675300
  • 财政年份:
    2012
  • 资助金额:
    $ 5.36万
  • 项目类别:
    Priority Programmes
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了